Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial is a research paper published in Journal of Antimicrobial Chemotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 45 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: UM1 AI068634
National Institutes of Health
Grant: UM1 AI068636
National Institutes of Health
Grant: UM1 AI106701
National Institute of Allergy and Infectious Diseases
Grant: U01 AI068632
National Institute of Mental Health
Grant: AI068632
NIAID NIH HHS
Grant: UM1 AI068632
NIAID NIH HHS
Grant: UM1 AI069463
South African National Research Foundation SARChi Chair in Paediatric Tuberculosis
University of Cape Town Clinical PK Laboratory
Adult Clinical Trial Group
NICHD NIH HHS
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Infant Maternal Pediatric Adolescent AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases
NICHD NIH HHS
FWCI
2.23
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals